Li-Huei Tsai receives The Hans Wigzell Research Foundation’s science prize amounting to USD 100,000
The Hans Wigzell Research Foundation (Hans Wigzells forskningsstiftelse) will today award
its third annual scientific prize to the neuroscientist Professor Li-Huei Tsai at
Massachusetts Institute of Technology (MIT) in Cambridge, USA. Professor Tsai is to
receive the prize of USD 100,000 for her pioneering research on the causes and possible
therapy of Alzheimer’s disease.
The research, carried out at Picower Institute for Learning and Memory Department of Brain
and Cognitive Sciences Massachusetts Institute of Technology has rapidly resulted in
ongoing, advanced clinical trials on Alzheimer’s patients, and has attracted considerable
interest in the medical world.
Part of the foundation’s citation reads:
“Professor Li-Huei Tsai at MIT has made a number of impressive findings in Alzheimer’s
disease. In her research she has been involved in developing completely new methods that,
through selective light stimulation in animal experiments, have been able to cause
Alzheimer’s disease mice to drastically improve in their disease.”
Rhenman & Partners Asset Management is the initiator and founder of the research
foundation.
For more information, please contact:
Hans Wigzells Forskningsstiftelse
E-mail: hw@forskningsstiftelse.se
About Li-Huei Tsai
Professor and Director of Picower Institute for Learning and Memory Department of Brain
and Cognitive Sciences, Massachusetts Institute of Technology
Li-Huei Tsai received her Ph.D degree from the University of Texas Southwestern Medical
Center at Dallas. Dr. Tsai completed her postdoctoral work with Ed Harlow’s laboratory at
Cold Spring Harbor laboratory and Massachusetts General Hospital. In 1994, Dr. Tsai joined
the faculty in the Department of Pathology at Harvard Medical School and was named an
investigator of Howard Hughes Medical Institute in 1997. In 2006, she was appointed
Professor in the Department of Brain and Cognitive Sciences, and joined the Picower
Institute for Learning and Memory at MIT. In 2015, she co-founded the Aging Brain Initiative
at MIT.
HANS WIGZELLS
FORSKNINGSSTIFTELSE
About Hans Wigzell
Professor of Immunology, Karolinska Institutet
Former President of Karolinska Institutet, Chairman of KI’s Nobel Committee, Director
General of the Infectious Diseases Institute and National Bacteriological Laboratory. Hans
Wigzell is also a member of the Royal Swedish Academy of Sciences and the Royal Swedish
Academy of Engineering Sciences IVA.
About the Hans Wigzell Research Foundation
The foundation promotes its support of scientific research and education in the medical
field, in particular through scholarships and other grants. It will also organize and/or support
seminars and conferences.
About Rhenman & Partners
Rhenman & Partners Asset Management, founded in 2008, is a Stockholm-based investment
management company focusing on two niche funds: Rhenman Healthcare Equity L/S,
founded in June 2009, and Rhenman Global Opportunities L/S, founded in August 2016.
Assets under management amount to approximately 6 billion SEK. Investment Teams of both
Funds are in their investment processes supported by renowned Advisory Boards, including
professors and experts with many years of market experience and extensive networks
around the world.